5 completed. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 5 |
Follow Thrombophilia: new trials by email Literature Review of Thrombophilia trials Research Report on Thrombophilia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Prophylactic Fibrinogen Concentrate In Scoliosis Surgery Fibrinogen Concentrate Human - Fibrinogen, Spine Deformity | Phase 4 | Completed | Brno University Hospital | 32 | 2022-06-06 | 2026-10-16 |
| Therapeutic Plasma Exchange for COVID-19-associated Hyperviscosity Therapeutic plasma exchange (TPE), Standard of care - COVID-19 | Phase 4 | Completed | Emory University | 20 | 2020-07-17 | 2022-12-21 |
| Efficacy and Safety of DLBS1033 in Subjects With Type 2 Diabetes Mellitus DLBS1033, placebo tablet of DLBS1033 - Type 2 Diabetes Mellitus | Phase 4 | Completed | Dexa Medica Group | 122 | 2013-05-01 | 2016-08-04 |
| Clinical Pharmacokinetics Study of ART-123 in Disseminated Intravascular Coagulation (DIC) Subjects With Renal Impairment ART-123 - Disseminated Intravascular Coagulation | Phase 4 | Completed | Asahi Kasei Therapeutics Corporation | 40 | 2012-10-01 | 2017-02-15 |
| The Effect of Heparin in Treatment IVF-ET Failure heparin - Pregnancy, Thrombophilia | Phase 4 | Completed | Yazd Medical University | 86 | 2009-05-01 | 2010-10-05 |
Disseminated Intravascular Coagulation (2) · COVID-19 (1) · Diabetes Mellitus, Type 2 (1) · Hemorrhage (1) · Hemostatic Disorders (1) · Scoliosis (1)
Hematologic Diseases (5) · Hemic and Lymphatic Diseases (5) · Blood Coagulation Disorders (2) · Hemorrhagic Disorders (2) · Bone Diseases (1) · Cardiovascular Diseases (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Diabetes Mellitus (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Infections (1) · Lung Diseases (1) · Metabolic Diseases (1)
ART123 (1) · DLBS 1033 (1) · Fibrinogen (1) · Heparin (1) · Plasma Exchange (1) · Standard of Care (1)
Asahi Kasei Therapeutics Corporation (1) · Brno University Hospital (1) · Dexa Medica Group (1) · Emory University (1) · Yazd Medical University (1)
Czechia (1) · Indonesia (1) · Iran (1) · Japan (1) · United States (1)
Asman Manaf, Prof. Dr. dr., SpPD-KEMD (1) · Cheryl Maier, MD, PhD (1) · Mehri Mashayekhy, infertility fellowship (1) · Roman Gal, M.D., PhD. (1)